Annual ROE
-1035.44%
-820.14%-380.93%
December 31, 2023
Summary
- As of February 7, 2025, EVOK annual return on equity is -1035.44%, with the most recent change of -820.14% (-380.93%) on December 31, 2023.
- During the last 3 years, EVOK annual ROE has risen by +1221.09% (+54.11%).
- EVOK annual ROE is now -10192.01% below its all-time high of 10.26%, reached on December 31, 2012.
Performance
EVOK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-433.12%
+572.11%+56.91%
September 30, 2024
Summary
- As of February 7, 2025, EVOK quarterly return on equity is -433.12%, with the most recent change of +572.11% (+56.91%) on September 30, 2024.
- Over the past year, EVOK quarterly ROE has increased by +749.01% (+63.36%).
- EVOK quarterly ROE is now -121.32% below its all-time high of 2031.54%, reached on December 31, 2020.
Performance
EVOK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
EVOK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -380.9% | +63.4% |
| 3 y3 years | +54.1% | -112.8% |
| 5 y5 years | -450.9% | -112.8% |
EVOK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -380.9% | +79.3% | -156.9% | +67.1% |
| 5 y | 5-year | -536.5% | +79.3% | -121.3% | +82.2% |
| alltime | all time | <-9999.0% | +79.3% | -121.3% | +82.2% |
Evoke Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -433.12%(-56.9%) |
| Jun 2024 | - | -1005.23%(-23.6%) |
| Mar 2024 | - | -1316.11%(+11.3%) |
| Dec 2023 | -1035.44%(+380.9%) | -1182.13%(+254.5%) |
| Sep 2023 | - | -333.45%(+63.8%) |
| Jun 2023 | - | -203.56%(+2.4%) |
| Mar 2023 | - | -198.71%(+7.7%) |
| Dec 2022 | -215.30%(-95.7%) | -184.42%(+4.8%) |
| Sep 2022 | - | -176.05%(+2.4%) |
| Jun 2022 | - | -171.84%(+1.9%) |
| Mar 2022 | - | -168.60%(-25.4%) |
| Dec 2021 | -5015.38%(+122.3%) | -225.98%(-33.6%) |
| Sep 2021 | - | -340.49%(-20.9%) |
| Jun 2021 | - | -430.29%(-82.3%) |
| Mar 2021 | - | -2429.86%(-219.6%) |
| Dec 2020 | -2256.53%(+1287.2%) | 2031.54%(-306.6%) |
| Sep 2020 | - | -983.42%(+152.1%) |
| Jun 2020 | - | -390.16%(+164.1%) |
| Mar 2020 | - | -147.72%(-1.7%) |
| Dec 2019 | -162.67%(-13.5%) | -150.21%(-6.4%) |
| Sep 2019 | - | -160.43%(+2.8%) |
| Jun 2019 | - | -156.13%(-7.6%) |
| Mar 2019 | - | -168.98%(+7.1%) |
| Dec 2018 | -187.96% | -157.77%(+11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -141.17%(-49.9%) |
| Jun 2018 | - | -281.57%(+18.2%) |
| Mar 2018 | - | -238.17%(-7.8%) |
| Dec 2017 | -564.69%(+99.0%) | -258.43%(-1.3%) |
| Sep 2017 | - | -261.76%(+35.2%) |
| Jun 2017 | - | -193.68%(-42.6%) |
| Mar 2017 | - | -337.65%(-39.4%) |
| Dec 2016 | -283.78%(-18.9%) | -556.84%(-13.1%) |
| Sep 2016 | - | -640.44%(+10.9%) |
| Jun 2016 | - | -577.57%(+69.0%) |
| Mar 2016 | - | -341.76%(+37.6%) |
| Dec 2015 | -349.84%(+142.7%) | -248.42%(+26.2%) |
| Sep 2015 | - | -196.77%(+15.2%) |
| Jun 2015 | - | -170.84%(+31.4%) |
| Mar 2015 | - | -130.06%(+33.8%) |
| Dec 2014 | -144.17%(+976.7%) | -97.23%(+35.3%) |
| Sep 2014 | - | -71.85%(+54.5%) |
| Jun 2014 | - | -46.50%(+24.9%) |
| Mar 2014 | - | -37.23%(+20.7%) |
| Dec 2013 | -13.39%(-230.5%) | -30.85%(-116.6%) |
| Sep 2013 | - | 186.03%(+663.0%) |
| Jun 2013 | - | 24.38%(+29.4%) |
| Mar 2013 | - | 18.84%(+83.6%) |
| Dec 2012 | 10.26%(-102.4%) | 10.26% |
| Dec 2011 | -420.67% | - |
FAQ
- What is Evoke Pharma annual return on equity?
- What is the all time high annual ROE for Evoke Pharma?
- What is Evoke Pharma annual ROE year-on-year change?
- What is Evoke Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Evoke Pharma?
- What is Evoke Pharma quarterly ROE year-on-year change?
What is Evoke Pharma annual return on equity?
The current annual ROE of EVOK is -1035.44%
What is the all time high annual ROE for Evoke Pharma?
Evoke Pharma all-time high annual return on equity is 10.26%
What is Evoke Pharma annual ROE year-on-year change?
Over the past year, EVOK annual return on equity has changed by -820.14% (-380.93%)
What is Evoke Pharma quarterly return on equity?
The current quarterly ROE of EVOK is -433.12%
What is the all time high quarterly ROE for Evoke Pharma?
Evoke Pharma all-time high quarterly return on equity is 2031.54%
What is Evoke Pharma quarterly ROE year-on-year change?
Over the past year, EVOK quarterly return on equity has changed by +749.01% (+63.36%)